Adma Biologics (ADMA) Interest & Investment Income (2011 - 2025)
Adma Biologics (ADMA) reported Interest & Investment Income of $487000.0 for Q4 2025, down 18.56% on a YoY basis from $598000.0 in Q4 2024, and up 29.52% quarter-over-quarter from $376000.0 in Q3 2025.
Adma Biologics (ADMA) Interest & Investment Income (2011 - 2025) Analysis & Trends
Adma Biologics has reported Interest & Investment Income for 13 years, with the latest figure at $487000.0 in Q4 2025.
- For the quarter ending Q4 2025, Interest & Investment Income fell 18.56% year-over-year to $487000.0; the trailing twelve-month figure through Dec 2025 stood at $1.9 million (down 10.78% YoY), and the FY2025 full-year result was $1.9 million, down 10.78% from the prior year.
- Interest & Investment Income for Q4 2025 stood at $487000.0, up from $376000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $666000.0 in Q3 2024, with the low at $2269.0 in Q2 2022.
- Historically, Interest & Investment Income has averaged $283150.0 across 5 years, with a median of $380000.0 in 2024.
- Annual changes were most pronounced in 2021 — Interest & Investment Income slumped 91.11% — and 2023, when it soared 25116.32%.
- Adma Biologics' Interest & Investment Income stood at $2759.0 in 2021, then retreated by 12.03% to $2427.0 in 2022, then soared by 25116.32% to $612000.0 in 2023, then fell by 2.29% to $598000.0 in 2024, then dropped by 18.56% to $487000.0 in 2025.
- The last three Interest & Investment Income figures came in at $487000.0 (Q4 2025), $376000.0 (Q3 2025), and $400000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | 487,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 487,000.00 |
| Sep 30, 2025 | 376,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 608,000.00 |
| Dec 31, 2024 | 598,000.00 |
| Sep 30, 2024 | 666,000.00 |
| Jun 30, 2024 | 449,000.00 |
| Mar 31, 2024 | 384,000.00 |
| Dec 31, 2023 | 612,000.00 |
| Sep 30, 2023 | 423,000.00 |
| Jun 30, 2023 | 414,000.00 |
| Mar 31, 2023 | 166,000.00 |
| Dec 31, 2022 | 2,427.00 |
| Sep 30, 2022 | 7,236.00 |
| Jun 30, 2022 | 2,269.00 |
| Mar 31, 2022 | 33,068.00 |
| Dec 31, 2021 | 2,759.00 |
| Sep 30, 2021 | 4,256.00 |
| Jun 30, 2021 | 5,926.00 |
| Mar 31, 2021 | 22,059.00 |